AKILI INTERACTIVE LABS
Akili Interactive Labs their broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and psychiatry, including attention-deficit hyperactivity and disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD) and various inflammatory diseases.
AKILI INTERACTIVE LABS
Industry:
Biotechnology Health Care Medical Neuroscience Service Industry Software Therapeutics
Founded:
2011-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.akiliinteractive.com
Total Employee:
51+
Status:
Active
Contact:
+1 415-419-5503
Total Funding:
270.59 M USD
Technology used in webpage:
Domain Not Resolving Apple Mobile Web Clips Icon Amazon Mobile Non Scaleable Content Cloudflare Hosting Cloudflare CDN Cloudflare CrUX Top 50m DNSSEC Apple Mobile Web App Capable
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Disc Medicine
Disc Medicine is a hematology company
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Kaia Health
Kaia Health is a digital therapeutics company that creates evidence-based treatments for a range of medical disorders.
Spinogenix
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Fearless Ventures
Fearless Ventures investment in Series D - Akili Interactive Labs
Omidyar Technology Ventures
Omidyar Technology Ventures investment in Series D - Akili Interactive Labs
Shionogi
Shionogi investment in Series D - Akili Interactive Labs
QUAD Investment Management
QUAD Investment Management investment in Series D - Akili Interactive Labs
Jazz Venture Partners
Jazz Venture Partners investment in Series D - Akili Interactive Labs
M Ventures
M Ventures investment in Series D - Akili Interactive Labs
Neuberger Berman
Neuberger Berman investment in Series D - Akili Interactive Labs
David Baszucki
David Baszucki investment in Series D - Akili Interactive Labs
Mirae Asset
Mirae Asset investment in Series D - Akili Interactive Labs
Evidity Health Capital
Evidity Health Capital investment in Series D - Akili Interactive Labs
Newest Events participated
Participated in Experiential Technology Conference & Expo 2017
on 2017-03-14 as sponsor
Participated in Experiential Technology Conference & Expo 2017
on 2017-03-14 as exhibitor
Participated in Experiential Technology and NeuroGaming Conference & Expo 2016
on 2016-05-17 as exhibitor
Key Employee Changes
Official Site Inspections
http://www.akiliinteractive.com Semrush global rank: 569.42 K Semrush visits lastest month: 57.3 K
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Akili Interactive Labs"
Akili Interactive Labs - Crunchbase Company Profile
Contact Email [email protected] Phone Number +1 415-419-5503 Akili Interactive Labs their broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and …See details»
PureTech Founded Entity Akili Interactive and Virtual Therapeutics ...
BOSTON, May 29, 2024--PureTech Founded Entity Akili Interactive and Virtual Therapeutics Enter Into Definitive Merger Agreement to Establish Leading Digital Health CompanySee details»
PureTech Founded Entity Akili Interactive and Virtual Therapeutics ...
May 29, 2024 Contact For Akili Matt Franklin, President and Chief Executive Officer [email protected] or [email protected] For Virtual Therapeutics …See details»
Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger ...
May 29, 2024 KIRKLAND, Wash. & BOSTON, May 29, 2024--Virtual Therapeutics, a company focused on improving mental health at scale using engaging, immersive games, and Akili, Inc. …See details»
Akili - LinkedIn
Core to Akili is the belief that quality evidence generation and clinical validation are paramount to digital therapeutics. Another great initiative we are proud to share this week is the study we ...See details»
Akili Interactive Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Akili Interactive. Use the PitchBook Platform to explore the full profile.See details»
Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger ...
Jun 20, 2024 Following completion of the transaction, the combined organization will operate as Virtual Therapeutics, a privately held company, with Akili operating as a wholly owned …See details»
Akili Announces Veteran Life Sciences Executive Matt Franklin in …
Jun 6, 2022 As President and COO, Franklin will join Martucci and Akili’s executive leadership team to scale the organization and bring Akili’s diverse pipeline of cognitive treatments to …See details»
Akili Announces Public Company Board of Director Nominees
Jul 11, 2022 Since February 2017, he has served on the board of the Digital Therapeutics Alliance, a digital therapeutics industry advocacy organization. Dr. Martucci holds a B.S. in …See details»
Akili Interactive Company Profile - Office Locations ... - Craft
Akili Interactive has 5 employees across 2 locations and $300.9 m in total funding,. See insights on Akili Interactive including office locations, competitors, revenue, financials, executives, …See details»
Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger ...
May 29, 2024 Following completion of the transaction, the combined organization will operate as Virtual Therapeutics, a privately held company, with Akili operating as a wholly owned …See details»
Akili Interactive, a Leader in Digital Medicine, to Become Publicly ...
Jan 26, 2022 For more information, please visit www.akiliinteractive.com. About Social Capital. At Social Capital, we make big bets on transformational ideas, technology, and people. We …See details»
Akili Interactive - Digital Therapeutics Alliance
Akili Interactive is a leading digital therapeutics company combining scientific and clinical rigor with the ingenuity of the tech industry to reinvent medicine. Akili is pioneering the development …See details»
Science & Technology — Akili Interactive
Explore the science and technology behind our digital treatments. Developed through the collaboration of world-renowned cognitive neuroscientists and acclaimed entertainment and …See details»
Akili Grows Leadership Team with Chief Financial Officer and …
Apr 11, 2019 Santosh Shanbhag joins Akili as Chief Financial Officer. Jacqueline Studer joins Akili as Senior Vice President and General Counsel . BOSTON, Mass., April 11, 2019 – Akili …See details»
Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger ...
May 29, 2024 For Akili Matt Franklin, President and Chief Executive Officer [email protected] or [email protected] For Virtual Therapeutics …See details»
Akili Announces Veteran Life Sciences Executive Matt Franklin in …
Jun 6, 2022 For more information, please visit www.akiliinteractive.com. Forward-Looking Statements This communication may contain certain forward-looking statements within the …See details»
Akili Secures $160 Million in Financing; Poised to Deliver on the ...
May 26, 2021 Julie DiCarlo, Akili [email protected] Release Summary Akili closes $160 Million Series D financing to accelerate commercialization of EndeavorRx™, expand tech to …See details»
Product Development — Akili Interactive
Product Development We take breakthrough science from the lab to patients in the form of effective and captivating digital therapeutics. We uncover groundbreaking neuroscience from …See details»